Danon disease: clinical features, evaluation, and management
- PMID: 25228319
- PMCID: PMC4169002
- DOI: 10.1161/CIRCHEARTFAILURE.114.001105
Danon disease: clinical features, evaluation, and management
Keywords: cardiomyopathy, dilated; cardiomyopathy, hypertrophic; genetics; glycogen storage disease type IIb; lysosomal-associated membrane protein 2; molecular biology; mutation.
Conflict of interest statement
None.
Figures
References
-
- Danon MJ, Oh SJ, DiMauro S, Manaligod JR, Eastwood A, Naidu S, Schliselfeld LH. Lysosomal glycogen storage disease with normal acid maltase. Neurology. 1981;31:51–57. - PubMed
-
- Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, Mora M, Riggs JE, Oh SJ, Koga Y, Sue CM, Yamamoto A, Murakami N, Shanske S, Byrne E, Bonilla E, Nonaka I, DiMauro S, Hirano M. Primary lamp-2 deficiency causes x-linked vacuolar cardiomyopathy and myopathy (danon disease) Nature. 2000;406:906–910. - PubMed
-
- Taylor MR, Ku L, Slavov D, Cavanaugh J, Boucek M, Zhu X, Graw S, Carniel E, Barnes C, Quan D, Prall R, Lovell MA, Mierau G, Ruegg P, Mandava N, Bristow MR, Towbin JA, Mestroni L, Registry FC. Danon disease presenting with dilated cardiomyopathy and a complex phenotype. J Hum Genet. 2007;52:830–835. - PubMed
-
- Froissart R, Maire I. Danon disease. Orphanet Encyclopedia. 2004 https://www.orpha.net/data/patho/GB/uk-Danon.pdf.
-
- Nishino I. Autophagic vacuolar myopathy. Semin Pediatr Neurol. 2006;13:90–95. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
